Platelet analysis in patients with haematological diseases with increased risk of thrombosis and bleeding

Platelet analysis in patients with haematological diseases with increased risk of thrombosis and bleeding - PART

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55308

Enrollment

102

Registered

2020-03-27

Start date

2019-10-29

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bleeding thrombosis

Interventions

None listed

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients with hematological disease and drugs with increased bleeding or thrombosis risk For cases: with thrombosis or bleeding For controls: without bleeding or thrombosis

Exclusion criteria

Exclusion criteria: - 1 platelet inhibiting drug

Design outcomes

Primary

Measure	Time frame
Determinants - Extent of thrombus formation and platelet activation under flow - Cytosolic calcium activation in platelets - Platelet leukocyte complex formation - Platelet protein expression Outcome Bleeding or thrombosis	—

Secondary

Measure	Time frame
Difference of platelet assays in cases vs. controls	—

Countries

Netherlands

Outcome results